Magnetic Resonance Elastography (MRE) – Non-Invasive Liver Fibrosis Staging
FibroScan is effective for most patients, but it has limits – it underperforms in obesity, ascites, and narrow intercostal spaces. MRE (Magnetic Resonance Elastography) is the most accurate non-invasive method available for liver fibrosis staging, measuring stiffness across the whole liver using MRI. For patients where FibroScan results are unreliable or intermediate, MRE provides a more definitive answer – and simultaneously measures liver fat fraction, making it uniquely valuable in MASLD. I am Dr Chetan Kalal, DM Hepatologist at Gleneagles Hospital Mumbai.
What Is MRE?
MRE uses a standard MRI scanner with one addition: a small mechanical driver placed on the patient’s right upper abdomen generates low-frequency vibrations (60 Hz). These shear waves travel through the liver. The MRI scanner measures how the waves propagate – stiffer tissue transmits waves at higher velocity. The result is a colour-coded stiffness map of the entire liver, reported in kilopascals (kPa).
Unlike FibroScan (transient elastography), which samples a small cylinder of liver, MRE images the whole organ. This larger sampling volume reduces the variability caused by focal lesions or patchy fibrosis – a particular advantage in advanced disease where fibrosis is not uniformly distributed.
When combined with MRI-PDFF (proton density fat fraction), MRE provides simultaneous, quantitative assessment of both fibrosis and steatosis – the two key parameters in MASLD (metabolic-associated steatotic liver disease) monitoring.
MRE Fibrosis Thresholds
Published thresholds vary slightly across studies and MRI systems, but the commonly referenced values are:
- F0-F1 (no/mild fibrosis): <2.5-3.0 kPa
- F2 (moderate fibrosis): 3.0-3.6 kPa
- F3 (advanced fibrosis): 3.6-5.0 kPa
- F4 (cirrhosis): >5.0 kPa
These are approximate. The exact threshold used depends on the MRI field strength (1.5T vs 3T), the algorithm, and the clinical context. Dr Kalal will interpret the result alongside clinical data, liver function tests, and imaging findings – the number alone does not determine management.
When Is MRE Preferred Over FibroScan?
Obesity / High BMI
FibroScan has a 15-20% failure rate in patients with BMI >30 and unreliable results at BMI >35. MRE is unaffected by body habitus.
Ascites
Ascites prevents FibroScan from working. MRE can be performed regardless of ascites volume.
Intermediate FibroScan Results
A FibroScan result in the grey zone (e.g., 8-12 kPa) that doesn’t clearly distinguish F2 from F3 can be resolved with MRE.
MASLD Monitoring
Combined MRE + MRI-PDFF tracks both fibrosis and fat fraction change over time – ideal for monitoring GLP-1 agonist or lifestyle therapy response.
Research / Clinical Trials
MRE is increasingly used as a non-invasive primary endpoint in NASH/MASLD trials given its accuracy and reproducibility.
Narrow Intercostal Space
Some patients have a small acoustic window for FibroScan. MRE bypasses this anatomical limitation.
What to Expect During MRE
MRE is performed in the MRI scanner – no injections, no radiation. A driver paddle is placed against the right side of your abdomen and generates a gentle, low-frequency buzz (not painful). You lie inside the MRI tube for approximately 30-45 minutes with brief breath-holds during image acquisition. If you are claustrophobic, the radiologist can prescribe a mild anxiolytic. Patients with cardiac pacemakers, certain metallic implants, or aneurysm clips may not be suitable for MRI – this is screened in advance.
Results are reviewed by the radiologist and interpreted by Dr Kalal in the context of your full clinical picture at your follow-up appointment.
Discuss MRE With Dr Kalal
If your FibroScan results are indeterminate, or if you have MASLD and need accurate fibrosis staging alongside fat quantification, MRE may be the right next test. Book a consultation at Gleneagles Hospital, Mumbai.